[HTML][HTML] Positron emission tomography (PET) in oncology
A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
[HTML][HTML] An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases
For decades, conventional nuclear medicine techniques have been utilized for the
assessment of many infectious and inflammatory diseases. Most of these techniques have …
assessment of many infectious and inflammatory diseases. Most of these techniques have …
[PDF][PDF] Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
HA Wieder, BLDM Brucher… - Journal of Clinical …, 2004 - researchgate.net
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous
Cell Carcinoma and Response to Treatment Page 1 Time Course of Tumor Metabolic Activity …
Cell Carcinoma and Response to Treatment Page 1 Time Course of Tumor Metabolic Activity …
[HTML][HTML] Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography
Background: The diagnosis of malignant mesothelioma is a challenging medical problem.
CT often cannot differentiate between benign diffuse pleural thickening and malignant …
CT often cannot differentiate between benign diffuse pleural thickening and malignant …
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review
LF de Geus-Oei, D Vriens… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Molecular imaging with 18 F-FDG PET has been proven useful in the management of
colorectal cancer. 18 F-FDG PET plays a pivotal role in staging before surgical resection of …
colorectal cancer. 18 F-FDG PET plays a pivotal role in staging before surgical resection of …
[HTML][HTML] Optimal imaging strategies for rectal cancer staging and ongoing management
S Balyasnikova, G Brown - Current treatment options in oncology, 2016 - Springer
Opinion statement Imaging determines the optimal treatment for rectal cancer patients. High-
resolution magnetic resonance imaging (MRI) overcomes many of the known limitations of …
resolution magnetic resonance imaging (MRI) overcomes many of the known limitations of …
Functional imaging of inflammatory diseases using nuclear medicine techniques
S Basu, H Zhuang, DA Torigian, J Rosenbaum… - Seminars in nuclear …, 2009 - Elsevier
Molecular imaging with positron emission tomography (PET) and single-photon emission
computed tomography (SPECT) is increasingly used to diagnose, characterize, and monitor …
computed tomography (SPECT) is increasingly used to diagnose, characterize, and monitor …
18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax
Y Demura, T Tsuchida, T Ishizaki… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Recent reports have indicated the value and limitations of 18F-FDG PET and 201Tl SPECT
for determination of malignancy. We prospectively assessed and compared the usefulness …
for determination of malignancy. We prospectively assessed and compared the usefulness …
[HTML][HTML] PET radiopharmaceuticals for specific bacteria imaging: a systematic review
Background: Bacterial infections are still one of the main factors associated with mortality
worldwide. Many radiopharmaceuticals were developed for bacterial imaging, both with …
worldwide. Many radiopharmaceuticals were developed for bacterial imaging, both with …
Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody
MK Robinson, M Doss, C Shaller, D Narayanan… - Cancer Research, 2005 - AACR
Positron emission tomography (PET) provides an effective means of both
diagnosing/staging several types of cancer and evaluating efficacy of treatment. To date, the …
diagnosing/staging several types of cancer and evaluating efficacy of treatment. To date, the …